RET comprehensive analysis-994

Test info

  
RET comprehensive analysis
  
994
  
LAB994
  
MSO
  
Familial Cancer testing
Hereditary Cancer testing
Inherited Cancer testing
Multiple Endocrine Neoplasia, type 2
MEN2
  
Genes included: RET
  

This assay is intended for patients with a history consistent with Multiple Endocrine Neoplasia, type 2.

Specimen

  
EDTA whole blood
  
  
10 mL
  
7 mL
  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  

Lavender (EDTA), 10mL

  
ACD whole blood
  

Yellow ACD (A or B)

  

  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  

Yellow ACD (A or B)

  

Ambient (preferred) – 60 days

Refrigerated – 60 days

Frozen - NO

  
Whole blood - 4 weeks
DNA - 8 weeks
  
  • Frozen specimen
  • Leaking tube
  • Clotted specimen
  • Hemolysis
  • Quantity not sufficient for analysis (QNS)
  • Incorrect anticoagulant

Performance

  
LabCorp (483472): R-NX
  
As needed
  
20 - 28 days
  

The coding region and flanking splice sites are analyzed by NGS (+/-10bp) and deletion/duplication analysis. Exon-level deletions/duplications are assessed by aCGH. Clinically significant findings are confirmed by Sanger sequencing or qPCR. Results are reported using ACMG guidelines and nomenclature recommended by the Human Genome Variation Society (HGVS).

Clinical and Interpretive info

  

An interpretive report will be included

Billing

  
81406
81479
  
Yes
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

Tracking

  
07/30/2021
  
12/21/2023
  
12/21/2023